Reporting for the family-office world.

Join the Family Office Networks Webinar Series Featuring Trac Unicorn Fund “A Quantitative Venture Firm Investing in Future Unicorns”. TRAC is a new kind of quantitative early-stage venture firm. The unique predictive technology combines superhuman forecasters and machine intelligence to accurately predict future unicorns early and with an overall accuracy 60%.

Join the Family Office Networks Webinar Series Featuring Innovative Medicine Partners (IMP). Innovative Medicine Partners (IMP) is a dynamic network of medical visionaries working in collaboration to develop novel medical procedures and devices. Our expert team of clinicians, scientists, engineers, legal advisors, regulatory specialists, marketing experts, and financial professionals possesses an unparalleled level of experience in all aspects required to bring medical devices from concept to commercialization.

Emerald Park Capital (EPC) is an emerging manager actively providing capital to the legal cannabis industry – Currently raising flagship fund of up to $110 million. Current market factors combined with positive industry dynamics present investors with excellent investment opportunities and risk adjusted returns Despite COVID-19, the cannabis industry has been deemed essential and continues to grow Typical investments include senior secured debt facilities and structured equity –Utilizing a combination of current yield and equity kickers – Strong enterprise level credit support provided by top tier borrowers EPC has built a team of seasoned investors and partners who have worked together on numerous deals over the past 10+ years, with a combined cannabis experience of 60+ completed transactions – Infrastructure support provided by EPC’s affiliate, Bryant Park Capital, a middle market investment bank that has advised in >300 closed transactions, representing >$30 billion in value

Come join the Family Office Networks’ Webinar Series featuring AltaThera Pharmaceuticals. AltaThera Pharmaceuticals is a commercial stage hospital-focused pharmaceutical company applying innovative science to address unmet medical needs while reducing healthcare costs. AltaThera is committed to providing therapies that increase efficient treatment of the complex challenges of atrial fibrillation (AFib), a serious and costly health problem.

Join the Family Office Networks Webinar Series Featuring AIR Asset Management. AIRAM advises and manages investment vehicles that provide unique opportunities within the alternative investment space to qualified investors. AIRAM focuses on life settlements and other longevity-linked investment products. Richard Beleutz, Chief Executive Officer and Scott Romanek, Managing Director of Sales & Marketing will discuss how they leverage the proficiency and experience of an extensive network of strategic partners to deploy investment strategies.

Join the Family Office Networks’ Webinar Series featuring Soligenix, Inc. Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The Focus: A Specialized BioTherapeutics business segment dedicated to the development of products for orphan diseases and areas of unmet medical need in oncology and inflammation. A Public Health Solutions business segment, funded entirely by the US Government to the amount of approximately $70 million to date, developing vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, emerging and antibiotic resistant infectious disease, and viral disease including Ebola, Marburg and COVID-19. Nasdaq: SNGX Stock Snapshot as of 10/01/20 Market Cap: ~ $53.7 Million Stock Price: $1.80 Avg Daily Vol (50D): ~ 1.1M Shares Outstanding: ~ 29.8 Million

Join the Family Office Networks’ Webinar Series featuring IQ-EQ. IQ-EQ will tell you it is now more important than ever before to identify the right analytical tools and data that can help investors in assessing their investment decisions. Indeed, without fresh information, processed at the speed at which markets are moving, investment professionals could be operating sub-optimally—at a critical time. IQ-EQ believes that some investors may need to consider how to reposition investment portfolios to navigate through these turbulent times with the right long-term objectives in mind. In this context, integrating ESG data capture into your portfolio reporting strategies could be an essential element of your long-term investment strategy.

Come join Family Office Networks for a discussion looking at how family offices are pooling resources to create synergies and generate alpha. Andrew P Schneider, Founder of Family Office Networks will be leading the presentation.

join the Family Office Networks’ Webinar Series featuring Alumni Venture Group. AVG, one of the nation’s most active pre-seed and seed venture investors, will show how individual and family investors can most effectively access promising early stage deals. They will walk through the keys of creating a smart seed portfolio by leveraging the Power Law, applying disciplined quality checks, and investing alongside established seed syndicates. They will also explain the importance of portfolio diversification and the “chase the winner” strategies deployed by top seed investor shops. Hear from AVG’s CEO and a Managing Partner from AVG’s Basecamp Fund, dedicated to seed investing, as they share their approach to seed deal selection and diversified portfolio creation. AVG will also outline its own investment funds and opportunities, with a special focus on seed and pre-seed stage opportunities. Finally, the presenters will bring the investment process to life with a sample of AVG seed deals.

Come Join the Family Office Networks Webinar Series Featuring Synergy Disc®. A Canadian medical device company dedicated to developing and commercializing next generation, minimally invasive spine technologies. SDRi’s marquee technology, the Synergy Disc, is the only artificial disc on the market that addresses motion and alignment for the treatment of degenerative disc disease in the cervical spine. The Technology: Synergy Disc ® is protected by over 55 patents Addressing alignment can expand the market to >50% more patients Over 950 Synergy Disc implants have been performed without any reported adverse events Early sales in UK, Germany & Australia Single-Arm FDA clinical trial starting in Oct 2020 The Investment Opportunity: SDRi is seeking $15M to complete its IDE clinical trial enrollment and 2-year follow-up, achieve US FDA PMA approval to access the US market, and fuel its outside the USA market opportunity. SDRi already has commitments for >$3M from existing shareholders. Validated by Strategic Shareholder – Top 3 Public Spine Device Company Prior exits in the spine artificial disc technology space have ranged from ~$100M – $1B, with an average exit value of $360M. With an attractive pre-money valuation of $41M, SDRi has promising return potential.

Come join the Family Office Network’s Webinar Series featuring the Women’s Livelihood Bond Series and find out why it is attracting investors from U.S, Europe, Australia and Asia. The US$150 million Women’s Livelihood Bond Series are high yield debt securities that finance a portfolio of women-focused SMEs in Asia Pacific, and are generating social and financial return for investors. Even in the face of COVID-19 and the economic downturn, the Women’s Livelihood Bond Series has been beating the market. Want to catch the ESG wave? Join the session and hear about: How past issuances are delivering social and financial returns to investors The details of the next issuance How investors can rebuild our economies and COVID-resilience through the Bond

Join the Family Office Networks Webinar Series Featuring the SoulPhysio Foundation. Aneesh Chaudhry, Philanthropist will share how SoulPhysio will Combat Mental and Neurological Illness in Children, with their primary focus being ASD (Autistic Spectrum Disorder). Their methods focus on bridging the gap between Eastern and Western Medicine to conduct research and fund treatment for complex Mental and Neurological cases at both of their Southern California clinics. They plan to Implement cutting edge wellness programs for inner city schools and families. What you will learn from this webinar: The future of treating Mental and Neurological Illness in children The Mindful Classroom and it’s focus on providing accessible wellness services to inner city schools and families The long-term vision of becoming a multi-billion dollar social enterprise